Major Shareholder Increases Stake in Shanghai Pharma by 38.6 Million H Shares

Deep News06-14

Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) (ASX: 02607) has announced that it received a notification from its controlling shareholder, Shanghai Industrial Investment (Group) Co., Ltd. (SIIC), on June 10, 2026.

The notification stated that between May 6, 2026, and June 10, 2026, SIIC, through its wholly-owned subsidiary SIIC International, acquired an additional 38.6 million H shares of the company.

Following this transaction, SIIC now holds 1,484,975,837 shares of the company, representing 40.04% of the total issued share capital of 3,708,361,809 shares.

The shares were acquired through open market purchases on the secondary market, with the funding for the share purchases coming from SIIC's own capital resources.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1184741387?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-14 12:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184741387","market":"sh","top_or_hot":-1,"title":"Major Shareholder Increases Stake in Shanghai Pharma by 38.6 Million H Shares","media":"Deep News","content":"<p>Shanghai Pharmaceuticals Holding Co., Ltd. (<b>SH PHARMA</b>) (<b>ASX: 02607</b>) has announced that it received a notification from its controlling shareholder, Shanghai Industrial Investment (Group) Co., Ltd. (SIIC), on June 10, 2026.<br><br>The notification stated that between May 6, 2026, and June 10, 2026, SIIC, through its wholly-owned subsidiary SIIC International, acquired an additional 38.6 million H shares of the company.<br><br>Following this transaction, SIIC now holds 1,484,975,837 shares of the company, representing 40.04% of the total issued share capital of 3,708,361,809 shares.<br><br>The shares were acquired through open market purchases on the secondary market, with the funding for the share purchases coming from SIIC's own capital resources.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Major Shareholder Increases Stake in Shanghai Pharma by 38.6 Million H Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMajor Shareholder Increases Stake in Shanghai Pharma by 38.6 Million H Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-06-14 12:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Pharmaceuticals Holding Co., Ltd. (<b>SH PHARMA</b>) (<b>ASX: 02607</b>) has announced that it received a notification from its controlling shareholder, Shanghai Industrial Investment (Group) Co., Ltd. (SIIC), on June 10, 2026.<br><br>The notification stated that between May 6, 2026, and June 10, 2026, SIIC, through its wholly-owned subsidiary SIIC International, acquired an additional 38.6 million H shares of the company.<br><br>Following this transaction, SIIC now holds 1,484,975,837 shares of the company, representing 40.04% of the total issued share capital of 3,708,361,809 shares.<br><br>The shares were acquired through open market purchases on the secondary market, with the funding for the share purchases coming from SIIC's own capital resources.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0187","symbol_name":"一线龙头","start_time":0,"source_url":"","article_id":"1184741387","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184741387","pubTimestamp":1781412029,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) (ASX: 02607) has announced that it received a notification from its controlling shareholder, Shanghai Industrial Investment (Group) Co., Ltd....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"601607":"上海医药","BK0187":"一线龙头","BK0184":"上海国资改革","BK0028":"国家队","BK0209":"零售","BK0097":"医药电商","BK0099":"上海本地重组","BK1197":"保健护理产品经销商","BK0020":"浦东新区","02607":"上海医药","BK0183":"MSCI概念","BK0188":"融资融券","BK0175":"白马股","BK0012":"证金概念","BK0196":"行业龙头"},"translate_title":"大股东增持上海医药3860万股H股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601607":1,"02607":1},"content_text":"Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) (ASX: 02607) has announced that it received a notification from its controlling shareholder, Shanghai Industrial Investment (Group) Co., Ltd. (SIIC), on June 10, 2026.The notification stated that between May 6, 2026, and June 10, 2026, SIIC, through its wholly-owned subsidiary SIIC International, acquired an additional 38.6 million H shares of the company.Following this transaction, SIIC now holds 1,484,975,837 shares of the company, representing 40.04% of the total issued share capital of 3,708,361,809 shares.The shares were acquired through open market purchases on the secondary market, with the funding for the share purchases coming from SIIC's own capital resources.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1184741387","isCrawlerRequest":true}